focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major licensing deal for Cambridge Sleep Sciences

6 Jun 2023 07:00

RNS Number : 7237B
Barkby Group PLC
06 June 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Barkby Group PLC

 

("Barkby" or the "Company")

 

 

Cambridge Sleep Sciences Announces Major Licensing Deal

 

Barkby (AIM: BARK) announces that its subsidiary, Cambridge Sleep Sciences, ("CSS") the science-based sleep technology business behind SleepHub®, has granted a five-year global license, (the "Agreement") to Sleep Sense International Limited, ("SSI") enabling it to manufacture a Smart Pillow using CSS's SleepEngine® platform.

 

Under the terms of the Agreement SSI holds exclusive rights in the pillow market subject to a Minimum Order Quantity, ("MOQ") of 25,000 units in the first 12 months. CSS will grant a 12-month extension of this exclusivity subject to a MOQ of 60,000 units for year two of the license.

 

Based on these MOQ's, CSS expects the license to generate royalty payments of £1.25 million in the first 12 months and £3.0 million in year two for the Company. MOQs and payments for years three, four and five will be agreed in November 2024.

 

Dr Julian Stone, CEO of CSS, said: 

"We are excited to be working with Sleep Sense International in such a large market. By embedding SleepEngine® we can now deliver our unique audio solution to aid and improve people's sleep through most third-party speakers, headphones and earbuds.

 

"The Agreement changes the market opportunity for us as we move the business towards a Software As A Service business model. We expect this licensing deal to be the first of many for SleepEngine®."

 

Mike Hobson, Managing Director of SSI said:

"We are really excited being partnered with CSS in this exciting new venture in creating the ultimate sleep product. With our experience of manufacturing quality natural sleep products combined with this new technology, developed with CSS, plus our global reach of customers new and old, we know this will change the whole conception of sleep."

 

SleepEngine® technology has been developed and refined over more than a decade by a team of researchers, scientists, sound and medical experts. The result is a unique audio solution that helps to retrain the brain to restore healthy natural sleep patterns, a key component for mental, physical, and cognitive wellbeing. SleepEngine® technology offers a unique integration opportunity with existing or new third-party products capable of delivering high quality audio.

 

SSI is a white label bedding company specialising in helping brands and retailers develop and launch new product propositions within the bedding category. Its brands include, Laura Ashley, Mammoth, Sleepeezee, Pillowheadzzzz, Airsprung, Millbrook and Staingard. 

 

CSS has agreed a separate global license for SleepEngine® with a multinational technology company and will be announcing more details shortly.

 

- Ends -

 

 

For more information

 

Barkby Group plc

Charles Dickson, Executive Chairman

 

c/o Montfort Communications

finnCap Ltd (Nomad and Broker)

Carl Holmes and Simon Hicks (Corporate Finance)

Tim Redfern and Richard Chambers (ECM)

 

+44 (0)20 7220 0500

Montfort

Olly Scott

Georgia Colkin

 

+44 (0)78 1234 5205

 

 

 

About Barkby

 

Barkby is a roadside real estate business focused on building and scaling a high-quality portfolio of modern, ESG-compliant assets. It is in the process of exiting its non-core investments, (comprising Workshop Coffee and Cambridge Sleep Sciences).

 

About Cambridge Sleep Sciences Ltd

Cambridge Sleep Sciences Ltd, part of the Life Sciences division of The Barkby Group Plc, develops technology which improves natural sleep. Using the principles of neuroscience and cutting-edge technology to enhance brain activity during sleep, its innovative solutions aim to improve health, wellbeing and enhance quality of life. 

 

The company prides itself on delivering the first neuroscience-based electronic sleep product, SleepHub®, to help improve and facilitate natural sleep. 

 

Find out more at: www.cambridgesleepsciences.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUDGGDLCDGDGXU
12
Date   Source Headline
27th Oct 20219:05 amRNSSecond Price Monitoring Extn
27th Oct 20219:00 amRNSPrice Monitoring Extension
27th Oct 20217:00 amRNSTrading Statement and Property Acquisition
10th Aug 20217:00 amRNSTrading Statement
16th Jun 20217:00 amRNSNew lease for The Ebrington Arms
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
7th May 20211:48 pmRNSResult of AGM and change of name
30th Apr 20217:00 amRNSInterim Results
15th Apr 20217:00 amRNSCambridge Sleep Sciences signs new partners
9th Apr 20217:00 amRNSPosting of Annual Report & Notice of AGM
8th Apr 20217:00 amRNSVerso Biosense signs collaboration agreement
31st Mar 20216:29 pmRNSFinal Results
25th Mar 20217:00 amRNSVerso Biosense signs agreement with hospital
11th Mar 20217:00 amRNSCambridge Sleep Sciences partnership announcement
3rd Mar 20217:00 amRNSTrading Update
25th Jan 20217:00 amRNSExchange of Contracts at Malden, Essex
24th Dec 20207:00 amRNSExtension of Warrants
21st Dec 20207:00 amRNSExercise of Warrants and Total Voting Rights
6th Nov 20207:03 amRNSExtension of Reporting Deadline
30th Oct 20207:00 amRNSWorkshop Coffee becomes UK Distributor for MiiR
23rd Oct 20207:00 amRNSCambridge Sleep Sciences Ltd launches 'SleepHub™'
30th Sep 20207:00 amRNSCompany Update and Issue of Equity
17th Sep 20207:00 amRNSNew lease for The Harcourt Arms
10th Aug 20207:00 amRNSPractical Completion of Hastings
3rd Aug 20207:00 amRNSInvestment in VivoPlex Group
22nd Jul 20207:00 amRNSUpdate and CBILS loan
21st Apr 20207:00 amRNSAgreement with Cambridge Sound Technologies
20th Apr 20207:32 amRNSVivoPlex prepares for clinical feasibility study
24th Mar 20202:57 pmRNSDirector/PDMR Shareholding
24th Mar 20207:00 amRNSConfirmation of Director Appointment
23rd Mar 20207:00 amRNSInterim Results
3rd Mar 20207:00 amRNSProposed acquisition
6th Feb 20207:00 amRNSAppointment of Senior Manager
3rd Feb 20207:00 amRNSAppointment of Chief Financial Officer
17th Jan 20207:00 amRNSExchange of Contracts at Huntingdon
7th Jan 20207:00 amRNSCompletion of Acquisition
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.